转移性肾细胞癌-话题@MedSci

#转移性肾细胞癌#

54篇内容 | 1985人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1420295, encodeId=b1e7142029586, content=<a href='/topic/show?id=5ed393430f3' target=_blank style='color:#2F92EE;'>#转移性肾细胞癌#</a>, objectTitle=Sci Rep：早期骨骼肌丢失是转移性肾细胞癌的预后生物标记, objectType=article, longId=109141, objectId=2f2010914185, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2f2010914185, replyNumber=0, likeNumber=54, createdTime=2017-08-19, rootId=0, userName=zhangyxzsh, userId=0da33575570, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2f2010914185, moduleTitle=Sci Rep：早期骨骼肌丢失是转移性肾细胞癌的预后生物标记, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2f2010914185)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1420294, encodeId=86421420294a2, content=<a href='/topic/show?id=5ed393430f3' target=_blank style='color:#2F92EE;'>#转移性肾细胞癌#</a>, objectTitle=JCO：Nivolumab联合ipilimumab——转移性肾细胞癌患者的新福音？, objectType=article, longId=105941, objectId=f13c1059413a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f13c1059413a, replyNumber=0, likeNumber=96, createdTime=2017-07-20, rootId=0, userName=zhangyxzsh, userId=0da33575570, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f13c1059413a, moduleTitle=JCO：Nivolumab联合ipilimumab——转移性肾细胞癌患者的新福音？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f13c1059413a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1420293, encodeId=9f8d1420293c6, content=<a href='/topic/show?id=5ed393430f3' target=_blank style='color:#2F92EE;'>#转移性肾细胞癌#</a>, objectTitle=JCO：Nivolumab联合Ipilimumab治疗转移性肾细胞癌, objectType=article, longId=105041, objectId=ab6110504191, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ab6110504191, replyNumber=0, likeNumber=69, createdTime=2017-07-11, rootId=0, userName=zhangyxzsh, userId=0da33575570, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ab6110504191, moduleTitle=JCO：Nivolumab联合Ipilimumab治疗转移性肾细胞癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ab6110504191)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1420292, encodeId=f7fb1420292db, content=<a href='/topic/show?id=5ed393430f3' target=_blank style='color:#2F92EE;'>#转移性肾细胞癌#</a>, objectTitle=ctDNA液体活检有望成为新一代转移性肾细胞癌诊断方法, objectType=article, longId=90665, objectId=3397906655a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3397906655a, replyNumber=0, likeNumber=74, createdTime=2017-03-05, rootId=0, userName=zhangyxzsh, userId=0da33575570, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3397906655a, moduleTitle=ctDNA液体活检有望成为新一代转移性肾细胞癌诊断方法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3397906655a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1420291, encodeId=e53814202912c, content=<a href='/topic/show?id=5ed393430f3' target=_blank style='color:#2F92EE;'>#转移性肾细胞癌#</a>, objectTitle=IKCS 14th：转移性肾细胞癌三线治疗的有效性, objectType=article, longId=58639, objectId=4cb358639dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4cb358639dc, replyNumber=0, likeNumber=88, createdTime=2015-11-12, rootId=0, userName=zhangyxzsh, userId=0da33575570, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4cb358639dc, moduleTitle=IKCS 14th：转移性肾细胞癌三线治疗的有效性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4cb358639dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1420290, encodeId=308b1420290cf, content=<a href='/topic/show?id=5ed393430f3' target=_blank style='color:#2F92EE;'>#转移性肾细胞癌#</a>, objectTitle=Lancet Oncol：Lenvatinib加依维莫司和lenvatinib单药治疗转移性肾细胞癌效果好, objectType=article, longId=57366, objectId=2de45e3662c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2de45e3662c, replyNumber=0, likeNumber=74, createdTime=2015-10-18, rootId=0, userName=zhangyxzsh, userId=0da33575570, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2de45e3662c, moduleTitle=Lancet Oncol：Lenvatinib加依维莫司和lenvatinib单药治疗转移性肾细胞癌效果好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2de45e3662c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1420289, encodeId=1ebb142028997, content=<a href='/topic/show?id=5ed393430f3' target=_blank style='color:#2F92EE;'>#转移性肾细胞癌#</a>, objectTitle=转移性肾细胞癌治疗的未来, objectType=article, longId=47675, objectId=ffcb4e67577, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ffcb4e67577, replyNumber=0, likeNumber=70, createdTime=2015-03-05, rootId=0, userName=zhangyxzsh, userId=0da33575570, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ffcb4e67577, moduleTitle=转移性肾细胞癌治疗的未来, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ffcb4e67577)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1420288, encodeId=23041420288a1, content=<a href='/topic/show?id=5ed393430f3' target=_blank style='color:#2F92EE;'>#转移性肾细胞癌#</a>, objectTitle=ASCO 2014 ：检查点抑制剂nivolumab可持续缓解转移性肾细胞癌, objectType=article, longId=36635, objectId=720e36635ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=720e36635ec, replyNumber=0, likeNumber=81, createdTime=2014-06-21, rootId=0, userName=zhangyxzsh, userId=0da33575570, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=720e36635ec, moduleTitle=ASCO 2014 ：检查点抑制剂nivolumab可持续缓解转移性肾细胞癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=720e36635ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1420287, encodeId=5414142028e5a, content=<a href='/topic/show?id=5ed393430f3' target=_blank style='color:#2F92EE;'>#转移性肾细胞癌#</a>, objectTitle=GICS 2014：减瘤性肾切除术可改善转移性肾细胞癌生存, objectType=article, longId=32019, objectId=6ef83201959, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6ef83201959, replyNumber=0, likeNumber=51, createdTime=2014-03-20, rootId=0, userName=zhangyxzsh, userId=0da33575570, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6ef83201959, moduleTitle=GICS 2014：减瘤性肾切除术可改善转移性肾细胞癌生存, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6ef83201959)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1420286, encodeId=1bc814202866a, content=<a href='/topic/show?id=5ed393430f3' target=_blank style='color:#2F92EE;'>#转移性肾细胞癌#</a>, objectTitle=JCO：tivozanib治疗转移性肾细胞癌PFS结局优于索拉非尼, objectType=article, longId=24472, objectId=9929244e2c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9929244e2c5, replyNumber=0, likeNumber=53, createdTime=2013-09-18, rootId=0, userName=zhangyxzsh, userId=0da33575570, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9929244e2c5, moduleTitle=JCO：tivozanib治疗转移性肾细胞癌PFS结局优于索拉非尼, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9929244e2c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1420285, encodeId=2fd014202850b, content=<a href='/topic/show?id=5ed393430f3' target=_blank style='color:#2F92EE;'>#转移性肾细胞癌#</a>, objectTitle=NEJM：帕唑帕尼治疗转移性肾细胞癌安全性优于舒尼替尼, objectType=article, longId=23774, objectId=d6ac23e74a8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d6ac23e74a8, replyNumber=0, likeNumber=73, createdTime=2013-09-05, rootId=0, userName=zhangyxzsh, userId=0da33575570, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d6ac23e74a8, moduleTitle=NEJM：帕唑帕尼治疗转移性肾细胞癌安全性优于舒尼替尼, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d6ac23e74a8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1420284, encodeId=e1e71420284fe, content=<a href='/topic/show?id=5ed393430f3' target=_blank style='color:#2F92EE;'>#转移性肾细胞癌#</a>, objectTitle=Lancet Oncol：阿西替尼可作为转移性肾细胞癌患者的二线治疗方案, objectType=article, longId=17730, objectId=efb91e73053, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=efb91e73053, replyNumber=0, likeNumber=78, createdTime=2013-04-26, rootId=0, userName=zhangyxzsh, userId=0da33575570, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=efb91e73053, moduleTitle=Lancet Oncol：阿西替尼可作为转移性肾细胞癌患者的二线治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=efb91e73053)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1420283, encodeId=45fd142028310, content=<a href='/topic/show?id=5ed393430f3' target=_blank style='color:#2F92EE;'>#转移性肾细胞癌#</a>, objectTitle=BJU Int：新研究可预测转移性肾细胞癌预后, objectType=article, longId=14687, objectId=55fe1468ecf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=55fe1468ecf, replyNumber=0, likeNumber=70, createdTime=2013-01-24, rootId=0, userName=zhangyxzsh, userId=0da33575570, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=55fe1468ecf, moduleTitle=BJU Int：新研究可预测转移性肾细胞癌预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=55fe1468ecf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1420282, encodeId=3acd1420282e8, content=<a href='/topic/show?id=5ed393430f3' target=_blank style='color:#2F92EE;'>#转移性肾细胞癌#</a>, objectTitle=MCP：定量蛋白质组学确定转移性肾细胞癌的生物标志物, objectType=article, longId=12765, objectId=75c912e659d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=75c912e659d, replyNumber=0, likeNumber=51, createdTime=2012-12-12, rootId=0, userName=zhangyxzsh, userId=0da33575570, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=75c912e659d, moduleTitle=MCP：定量蛋白质组学确定转移性肾细胞癌的生物标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=75c912e659d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1420281, encodeId=ebff142028108, content=<a href='/topic/show?id=5ed393430f3' target=_blank style='color:#2F92EE;'>#转移性肾细胞癌#</a>, objectTitle=ASCO 2012：转移性肾细胞癌的治疗若干进展, objectType=article, longId=7696, objectId=0ec8e69655, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ec8e69655, replyNumber=0, likeNumber=56, createdTime=2012-07-08, rootId=0, userName=zhangyxzsh, userId=0da33575570, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ec8e69655, moduleTitle=ASCO 2012：转移性肾细胞癌的治疗若干进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0ec8e69655)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

转移性肾细胞癌

2020-05-29

zhangyxzsh (审核中...)

前往app查看评论内容

#转移性肾细胞癌#

Sci Rep：早期骨骼肌丢失是转移性肾细胞癌的预后生物标记

2017-08-19

zhangyxzsh (审核中...)

前往app查看评论内容

#转移性肾细胞癌#

JCO：Nivolumab联合ipilimumab——转移性肾细胞癌患者的新福音？

2017-07-20

zhangyxzsh (审核中...)

前往app查看评论内容

#转移性肾细胞癌#

JCO：Nivolumab联合Ipilimumab治疗转移性肾细胞癌

2017-07-11

zhangyxzsh (审核中...)

前往app查看评论内容

#转移性肾细胞癌#

ctDNA液体活检有望成为新一代转移性肾细胞癌诊断方法

2017-03-05

zhangyxzsh (审核中...)

前往app查看评论内容

#转移性肾细胞癌#

IKCS 14th：转移性肾细胞癌三线治疗的有效性

2015-11-12

zhangyxzsh (审核中...)

前往app查看评论内容

#转移性肾细胞癌#

Lancet Oncol：Lenvatinib加依维莫司和lenvatinib单药治疗转移性肾细胞癌效果好

2015-10-18

zhangyxzsh (审核中...)

前往app查看评论内容

#转移性肾细胞癌#

转移性肾细胞癌治疗的未来

2015-03-05

zhangyxzsh (审核中...)

前往app查看评论内容

#转移性肾细胞癌#

ASCO 2014 ：检查点抑制剂nivolumab可持续缓解转移性肾细胞癌

2014-06-21

zhangyxzsh (审核中...)

前往app查看评论内容

#转移性肾细胞癌#

GICS 2014：减瘤性肾切除术可改善转移性肾细胞癌生存

2014-03-20

zhangyxzsh (审核中...)

前往app查看评论内容

#转移性肾细胞癌#

JCO：tivozanib治疗转移性肾细胞癌PFS结局优于索拉非尼

2013-09-18

zhangyxzsh (审核中...)

前往app查看评论内容

#转移性肾细胞癌#

NEJM：帕唑帕尼治疗转移性肾细胞癌安全性优于舒尼替尼

2013-09-05

zhangyxzsh (审核中...)

前往app查看评论内容

#转移性肾细胞癌#

Lancet Oncol：阿西替尼可作为转移性肾细胞癌患者的二线治疗方案

2013-04-26

zhangyxzsh (审核中...)

前往app查看评论内容

#转移性肾细胞癌#

BJU Int：新研究可预测转移性肾细胞癌预后

2013-01-24

zhangyxzsh (审核中...)

前往app查看评论内容

#转移性肾细胞癌#

MCP：定量蛋白质组学确定转移性肾细胞癌的生物标志物

2012-12-12

zhangyxzsh (审核中...)

前往app查看评论内容

#转移性肾细胞癌#

ASCO 2012：转移性肾细胞癌的治疗若干进展

2012-07-08

科室
- - 订阅+
  - 更多科室
工具
服务